Interpretable Machine Learning for Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound.


Journal

IEEE transactions on ultrasonics, ferroelectrics, and frequency control
ISSN: 1525-8955
Titre abrégé: IEEE Trans Ultrason Ferroelectr Freq Control
Pays: United States
ID NLM: 9882735

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 24 3 2022
medline: 30 4 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

This work proposes an interpretable radiomics approach to differentiate between malignant and benign focal liver lesions (FLLs) on contrast-enhanced ultrasound (CEUS). Although CEUS has shown promise for differential FLLs diagnosis, current clinical assessment is performed only by qualitative analysis of the contrast enhancement patterns. Quantitative analysis is often hampered by the unavoidable presence of motion artifacts and by the complex, spatiotemporal nature of liver contrast enhancement, consisting of multiple, overlapping vascular phases. To fully exploit the wealth of information in CEUS, while coping with these challenges, here we propose combining features extracted by the temporal and spatiotemporal analysis in the arterial phase enhancement with spatial features extracted by texture analysis at different time points. Using the extracted features as input, several machine learning classifiers are optimized to achieve semiautomatic FLLs characterization, for which there is no need for motion compensation and the only manual input required is the location of a suspicious lesion. Clinical validation on 87 FLLs from 72 patients at risk for hepatocellular carcinoma (HCC) showed promising performance, achieving a balanced accuracy of 0.84 in the distinction between benign and malignant lesions. Analysis of feature relevance demonstrates that a combination of spatiotemporal and texture features is needed to achieve the best performance. Interpretation of the most relevant features suggests that aspects related to microvascular perfusion and the microvascular architecture, together with the spatial enhancement characteristics at wash-in and peak enhancement, are important to aid the accurate characterization of FLLs.

Identifiants

pubmed: 35320099
doi: 10.1109/TUFFC.2022.3161719
pmc: PMC9188683
mid: NIHMS1802122
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1670-1681

Subventions

Organisme : NCI NIH HHS
ID : R01 CA215520
Pays : United States

Références

Abdom Radiol (NY). 2016 Jan;41(1):25-32
pubmed: 26830608
Radiology. 2018 Dec;289(3):816-830
pubmed: 30251931
Eur Radiol. 2017 Aug;27(8):3226-3234
pubmed: 28004162
AJR Am J Roentgenol. 2015 Jul;205(1):W56-66
pubmed: 26102419
Rofo. 2001 May;173(5):424-9
pubmed: 11414150
World J Gastroenterol. 2012 Aug 28;18(32):4427-34
pubmed: 22969209
IEEE Trans Med Imaging. 2016 Mar;35(3):713-27
pubmed: 26513779
Med Phys. 2016 Nov;43(11):5951
pubmed: 27806580
Abdom Radiol (NY). 2018 Apr;43(4):861-879
pubmed: 29151131
Sensors (Basel). 2021 Jun 16;21(12):
pubmed: 34208548
Comput Biol Med. 2015 Aug;63:229-37
pubmed: 25453358
J Ultrasound Med. 2021 Dec;40(12):2581-2593
pubmed: 33576003
IEEE Trans Ultrason Ferroelectr Freq Control. 2012 Apr;59(4):621-9
pubmed: 22547274
Radiology. 2011 Oct;261(1):300-10
pubmed: 21746815
Ultrasound Med Biol. 2019 Jun;45(6):1380-1396
pubmed: 30952468
Clin Hemorheol Microcirc. 2014;58(1):89-95
pubmed: 25227188
IEEE Trans Med Imaging. 2017 Jul;36(7):1427-1437
pubmed: 28141517
Ultraschall Med. 2012 Aug;33(4):344-51
pubmed: 22843433
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur Radiol. 2018 May;28(5):2077-2088
pubmed: 29189932
Radiology. 2004 Aug;232(2):420-30
pubmed: 15286314
Abdom Radiol (NY). 2018 Jan;43(1):127-142
pubmed: 28819825
Sci Rep. 2017 Aug 31;7(1):10117
pubmed: 28860628
Ultrasound Med Biol. 2016 Dec;42(12):2852-2863
pubmed: 27592557
IEEE Trans Ultrason Ferroelectr Freq Control. 2020 Aug;67(8):1497-1512
pubmed: 32091998
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Ultrasound Med Biol. 2020 Mar;46(3):518-543
pubmed: 31924424
Ultrasound Med Biol. 2013 Sep;39(9):1631-41
pubmed: 23791350
J Hepatol. 2018 Mar;68(3):485-492
pubmed: 29133247
Ultrasound Med Biol. 2019 Oct;45(10):2713-2724
pubmed: 31300222
Neural Comput. 1998 Sep 15;10(7):1895-1923
pubmed: 9744903
Radiol Imaging Cancer. 2020 Mar 27;2(2):e190014
pubmed: 33778701
Phys Med Biol. 2015 Jul 21;60(14):5471-96
pubmed: 26119045
IEEE J Biomed Health Inform. 2020 Oct;24(10):2860-2869
pubmed: 32149699
Curr Med Chem. 2000 Oct;7(10):995-1039
pubmed: 10911016
World J Hepatol. 2016 Mar 28;8(9):446-51
pubmed: 27028805
IEEE Trans Ultrason Ferroelectr Freq Control. 2010 Nov;57(11):2503-11
pubmed: 21041137
Ultrasonography. 2019 Oct;38(4):289-301
pubmed: 31311068
Cancer J. 2015 Jul-Aug;21(4):267-73
pubmed: 26222078
Ultrasound Med Biol. 2020 Oct;46(10):2579-2604
pubmed: 32713788
Gastroenterology. 2017 Mar;152(4):745-761
pubmed: 28043904
IEEE Trans Biomed Eng. 2017 Mar;64(3):661-670
pubmed: 28113214
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
Sci Rep. 2017 Jun 22;7(1):4041
pubmed: 28642480
Med Phys. 2015 Jul;42(7):3948-59
pubmed: 26133595
Liver Int. 2016 Jul;36(7):1026-32
pubmed: 26681659
Ultraschall Med. 2017 Jan;38(1):85-86
pubmed: 28249328
Comput Med Imaging Graph. 2018 Dec;70:155-164
pubmed: 30390573

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH